JP2014506259A5 - - Google Patents

Download PDF

Info

Publication number
JP2014506259A5
JP2014506259A5 JP2013548861A JP2013548861A JP2014506259A5 JP 2014506259 A5 JP2014506259 A5 JP 2014506259A5 JP 2013548861 A JP2013548861 A JP 2013548861A JP 2013548861 A JP2013548861 A JP 2013548861A JP 2014506259 A5 JP2014506259 A5 JP 2014506259A5
Authority
JP
Japan
Prior art keywords
seq
cdr
ligand
antibody
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013548861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014506259A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050633 external-priority patent/WO2012098113A1/en
Publication of JP2014506259A publication Critical patent/JP2014506259A/ja
Publication of JP2014506259A5 publication Critical patent/JP2014506259A5/ja
Withdrawn legal-status Critical Current

Links

JP2013548861A 2011-01-17 2012-01-17 Ｉｌ−２１リガンド Withdrawn JP2014506259A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP11151073 2011-01-17
EP11151073.1 2011-01-17
US201161434989P 2011-01-21 2011-01-21
US61/434,989 2011-01-21
EP11168328.0 2011-05-31
EP11168328 2011-05-31
US201161493002P 2011-06-03 2011-06-03
US61/493,002 2011-06-03
EP11187212 2011-10-31
EP11187212.3 2011-10-31
PCT/EP2012/050633 WO2012098113A1 (en) 2011-01-17 2012-01-17 Il-21 ligands

Publications (2)

Publication Number Publication Date
JP2014506259A JP2014506259A (ja) 2014-03-13
JP2014506259A5 true JP2014506259A5 (https=) 2015-03-05

Family

ID=46515179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013548861A Withdrawn JP2014506259A (ja) 2011-01-17 2012-01-17 Ｉｌ−２１リガンド

Country Status (5)

Country Link
US (1) US20130323259A1 (https=)
EP (1) EP2665750A1 (https=)
JP (1) JP2014506259A (https=)
CN (1) CN103443124A (https=)
WO (1) WO2012098113A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007111714A2 (en) 2005-11-28 2007-10-04 Zymogenetics, Inc. Il-21 antagonists
US20140178396A1 (en) 2012-12-21 2014-06-26 Novo Nordisk A/S Treatment of cardiovascular diseases
EP2746292A1 (en) 2012-12-21 2014-06-25 Novo Nordisk A/S Anti-IL21 antibodies for use in the treatment of nephropathies
EP3102603A1 (en) * 2014-02-07 2016-12-14 Novo Nordisk A/S Antibody process
AR099625A1 (es) 2014-03-21 2016-08-03 Lilly Co Eli Anticuerpos de il-21
WO2015169789A1 (en) * 2014-05-07 2015-11-12 Novo Nordisk A/S Treatment of diabetes type 1 using glp-1 and anti-il-21
PE20170441A1 (es) 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
MX2017015260A (es) 2015-06-03 2018-02-19 Squibb Bristol Myers Co Anticuerpos anti receptor de factor de necrosis tumoral inducible por glucocorticoide (gitr) para diagnostico del cancer.
AU2016356780A1 (en) 2015-11-19 2018-06-28 Bristol-Myers Squibb Company Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2380812T3 (es) 1999-12-23 2012-05-18 Genentech, Inc. Polipéptidos homólogos a IL-17 y usos terapéuticos de los mismos
SG177012A1 (en) * 2002-05-20 2012-01-30 Abmaxis Inc Generation and selection of protein library in silico
DK2270048T3 (en) * 2002-12-24 2016-01-18 Rinat Neuroscience Corp Anti-NGF antibodies and methods for their use
ITRM20040586A1 (it) * 2004-11-29 2005-02-28 Giuliani Spa Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
WO2007111714A2 (en) * 2005-11-28 2007-10-04 Zymogenetics, Inc. Il-21 antagonists
WO2007071061A1 (en) * 2005-12-23 2007-06-28 Viventia Biotech Inc. Methods for generating and screening fusion protein libraries and uses thereof
WO2009047360A1 (en) * 2007-10-11 2009-04-16 Novo Nordisk A/S Il-21 antibodies
US7883700B2 (en) 2007-12-07 2011-02-08 Zymogenetics, Inc. Anti-human IL-21 monoclonal antibodies
WO2009132821A1 (en) * 2008-04-28 2009-11-05 Giuliani International Limited Interleukin (il-21) binding proteins and methods of making and using same
TWI487712B (zh) * 2008-09-03 2015-06-11 建南德克公司 多重特異性抗體
SI2425008T1 (sl) * 2009-04-29 2015-12-31 Janssen Biotech, Inc. Antagonisti tollu podobnega receptorja 3

Similar Documents

Publication Publication Date Title
JP2014506259A5 (https=)
JP2014205674A5 (https=)
JP2019528240A5 (https=)
JP2014526898A5 (https=)
HRP20211343T1 (hr) Protutijela protiv dkk-1
HRP20210170T1 (hr) Protutijela protiv b7-h3 i konjugati protutijela s lijekom
JP2016196468A5 (https=)
JP2015532292A5 (https=)
JP2016502515A5 (https=)
JP2018507220A5 (https=)
NZ608206A (en) Antibodies that bind myostatin, compositions and methods
JP2014502955A5 (https=)
PH12018502623A1 (en) Anti-pd-l1 antibodies and uses thereof
JP2018508483A5 (https=)
JP2011046732A5 (https=)
HRP20201022T1 (hr) Potpuno ljudsko antitijelo protiv ljudskog cd137 i njegova uporaba
JP2020502996A5 (https=)
RU2571204C3 (ru) Специфические связывающие агенты против в7-н1
JP2015514110A5 (https=)
ME02533B (me) BISPECIFIČNA ANTITELA PROTIV CD3-EPSILON l BCMA
JP2016538830A5 (https=)
JP2013538057A5 (https=)
JP2015502138A5 (https=)
RU2016129517A (ru) Биспецифические антитела к her2 и способы применения
JP2016512551A5 (https=)